Cite
HARVARD Citation
Huffstutter, J. et al. (2014). THU0172 Symptomatic Subcutaneous Anti-Tumor Necrosis Factor-Treated Rheumatoid Arthritis Patients Respond to Golimumab following an Active Switch. Annals of the rheumatic diseases. p. 240. [Online].